Skip to main content

ADVERTISEMENT

In-stent restenosis

Calcium Corner
11/05/2014

Cath Lab Digest talks with Eric J. Dippel, MD, Genesis Heart Institute, Davenport, Iowa, and lead investigator for the EXCITE ISR trial.

Cath Lab Digest talks with Eric J. Di...
Data from the prospective, randomized Excimer Laser Atherectomy versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (EXCITE ISR) trial was presented on September 16th as a late-breaking clinical trial at the 2014...
Data from the prospective, randomized Excimer Laser Atherectomy versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (EXCITE ISR) trial was presented on September 16th as a late-breaking clinical trial at the 2014...
Data from the prospective,...
11/05/2014
Cath Lab Digest
Original Research
09/05/2008
Percutaneous transluminal renal angioplasty (PTRA) followed by subsequent stent implantation is an efficient treatment of atherosclerotic renal artery stenosis and has been shown to be associated with improvement in renal function, control of...
Percutaneous transluminal renal angioplasty (PTRA) followed by subsequent stent implantation is an efficient treatment of atherosclerotic renal artery stenosis and has been shown to be associated with improvement in renal function, control of...
Percutaneous transluminal renal...
09/05/2008
Vascular Disease Management
Commentary
09/05/2008
Stenting of the renal artery is now the procedure of choice in treating obstructive atherosclerotic renal artery disease. Unfortunately, restenosis remains the Achilles’ tendon of this percutaneous therapy, and ranges from 15–25%.
Stenting of the renal artery is now the procedure of choice in treating obstructive atherosclerotic renal artery disease. Unfortunately, restenosis remains the Achilles’ tendon of this percutaneous therapy, and ranges from 15–25%.
Stenting of the renal artery is...
09/05/2008
Vascular Disease Management